Workflow
CHALKIS(000972)
icon
Search documents
中基健康(000972) - 2020 Q1 - 季度财报
2020-04-29 16:00
Financial Performance - The company's revenue for Q1 2020 was ¥2,758,230.08, a decrease of 96.99% compared to ¥91,484,302.22 in the same period last year[8] - The net profit attributable to shareholders was -¥13,041,004.34, representing a 45.43% increase in losses compared to -¥8,966,936.17 in the previous year[8] - The basic earnings per share were -¥0.0169, a decline of 45.69% compared to -¥0.0116 in the previous year[8] - Operating revenue plummeted by 96.99% to ¥2,758,230.08 compared to ¥91,484,302.22, attributed to factory shutdowns and no product sales in the first quarter[15] - The net loss for Q1 2020 was CNY 13,053,465.20, compared to a net loss of CNY 9,035,125.01 in Q1 2019, reflecting an increase in losses of approximately 44%[36] - The total comprehensive loss for Q1 2020 was -¥13,053,465.20, compared to -¥9,035,125.01 in Q1 2019, indicating a year-over-year increase in losses of about 44.7%[37] Cash Flow - The net cash flow from operating activities was -¥4,790,684.39, which is a 63.16% improvement from -¥13,002,306.18 in the same period last year[8] - Cash received from sales dropped by 99.98% to ¥4,000.00 from ¥21,623,066.04, indicating no product sales during the quarter[15] - The cash inflow from operating activities was only ¥733,296.72 in Q1 2020, a sharp decline from ¥23,488,846.89 in Q1 2019, representing a decrease of about 96.9%[44] - The company incurred a total cash outflow of ¥48,005,077.36 from financing activities in Q1 2020, compared to ¥16,172,991.27 in Q1 2019, reflecting an increase in cash outflows of about 196.5%[45] - The total cash and cash equivalents at the end of Q1 2020 were ¥26,161,078.33, down from ¥78,956,840.08 at the beginning of the period, indicating a decrease of approximately 66.8%[45] Assets and Liabilities - Total assets at the end of the reporting period were ¥674,451,770.44, down 8.89% from ¥740,282,440.65 at the end of the previous year[8] - The total liabilities decreased from CNY 292,346,652.15 at the end of 2019 to CNY 239,569,447.14 by March 31, 2020, a reduction of about 18%[30] - The total equity attributable to shareholders decreased from CNY 441,936,607.51 at the end of 2019 to CNY 428,895,603.17 by March 31, 2020, a decline of approximately 3%[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 36,804[10] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., holds 16.18% of the shares[10] Operating Costs and Expenses - Operating costs fell by 96.18% to ¥3,347,191.68 from ¥87,733,345.57, reflecting the same shutdown issues[15] - Management expenses increased by 35.12% to ¥11,382,896.18 from ¥8,424,348.49 due to costs associated with the shutdown[15] - Operating expenses increased significantly, with costs rising to ¥1,752,877.32 in Q1 2020 from ¥324,951.77 in Q1 2019, marking a year-over-year increase of approximately 440.5%[39] Other Financial Metrics - The weighted average return on net assets was -3.00%, a decrease of 0.8 percentage points compared to -2.20% in the previous year[8] - The company reported no non-recurring gains or losses during the reporting period[8] - The company received no cash from investment recoveries, a 100% decrease from ¥12,889,980.00 in the previous period[16] - The company reported a financial expense of CNY 1,072,145.61 in Q1 2020, down from CNY 3,938,508.46 in the same period last year, a decrease of approximately 73%[36] Audit and Reporting - The company did not undergo an audit for the first quarter report[49] - The company did not apply new revenue and leasing standards for the current reporting period[49]
中基健康(000972) - 2019 Q4 - 年度财报
2020-04-15 16:00
Financial Performance - The company's operating revenue for 2019 was ¥213,188,826.11, a decrease of 65.98% compared to ¥626,669,589.53 in 2018[16] - The net profit attributable to shareholders in 2019 was ¥4,975,779.02, a significant recovery from a loss of ¥423,854,369.08 in 2018[16] - The net cash flow from operating activities decreased by 65.74% to ¥142,656,995.36 in 2019 from ¥416,334,994.00 in 2018[16] - The total assets at the end of 2019 were ¥740,282,440.65, down 39.65% from ¥1,226,692,417.36 at the end of 2018[16] - The net assets attributable to shareholders increased slightly by 0.79% to ¥441,936,607.51 at the end of 2019 from ¥438,488,610.56 at the end of 2018[16] - The basic earnings per share for 2019 was ¥0.01, recovering from a loss of ¥0.55 in 2018[16] - The weighted average return on net assets improved to 1.13% in 2019 from -64.39% in 2018, an increase of 65.52 percentage points[16] Dividend Policy - The company plans not to distribute cash dividends or issue bonus shares for the year[6] Business Operations - The company has not reported any changes in its main business since its listing[16] - The company has engaged Zhongxing Caiguanghua Accounting Firm for auditing, which issued an unqualified opinion with a paragraph on going concern uncertainty[5] - The company is undergoing a strategic transformation by shutting down certain factories to improve asset structure and reduce burdens[27] - The company is actively pursuing state-owned enterprise reforms to enhance market competitiveness and asset utilization efficiency[28] - The company has established a post-doctoral research workstation to foster talent and enhance technological innovation capabilities[30] - The company is focusing on optimizing resource allocation and improving asset quality to support sustainable development and profitability[29] Revenue Breakdown - The manufacturing sector contributed ¥197,338,730.57, accounting for 92.57% of total revenue, reflecting a 67.83% decline from the previous year[37] - The sales of bulk tomato sauce were ¥192,504,754.63, representing 90.30% of total revenue, down 62.96% year-on-year[38] Asset Management - The company disposed of non-current assets, generating a profit of ¥128,157,791.31 in 2019, compared to ¥120,782,592.49 in 2018[22] - The company is undergoing asset disposals to improve asset quality and enhance sustainable profitability[44] - The company has initiated the transfer of 100% equity in its subsidiary Zhongchen Canning, with an estimated value of ¥42,966,548.09[45] Legal Matters - The company has ongoing litigation against Master Company regarding a lease contract dispute, with claims for management fees and compensation totaling approximately 67.88 million CNY[90][95] - The court ruled that Master Company must pay 9.9947 million CNY in management fees and 18.1 million CNY for inventory losses[95] - The subsidiary Hongse Fanqie is involved in a lawsuit with Tianjin Coal Trading Company over a transportation and storage contract dispute[97] - Red Tomato has filed a lawsuit against Tianjin Coal Trading Company, claiming economic losses totaling RMB 20,981,923.85 due to various breaches of contract, including delayed shipments and misdelivery[100] Corporate Governance - The company is committed to improving its corporate governance and exploring long-term incentive mechanisms for employees[68] - The company has established a comprehensive corporate governance structure that complies with regulatory requirements[192] - The company operates independently from its controlling shareholder in business, personnel, assets, organization, and finance[193] Shareholder Information - The company reported a total share count of 771,283,579, with 100% being unrestricted shares[149] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., holds 16.18% of shares, totaling 124,769,223[152] Environmental Compliance - The company has established a wastewater treatment facility with a processing capacity of 450 m³/h, utilizing a secondary biochemical process[144] - The company has complied with environmental regulations and has obtained the necessary environmental impact assessments and discharge permits[144] Employee Information - The total remuneration for directors, supervisors, and senior management in 2019 amounted to 1.5149 million yuan (including tax) for 9 individuals[183] - The company employed a total of 67 staff members, with 27 in the parent company and 40 in major subsidiaries[186] Future Outlook - The company has set a revenue guidance of 1.5 billion RMB for the next fiscal year, projecting a growth rate of 25%[177] - New product launches are expected to contribute an additional 300 million RMB in revenue in the upcoming year[177] - The company is investing 100 million RMB in R&D for new technologies aimed at enhancing product efficiency[177]
中基健康(000972) - 2019 Q3 - 季度财报
2019-10-31 16:00
Financial Performance - Operating revenue fell by 99.21% to ¥799,854.20, with a year-to-date revenue decline of 54.07% to ¥201,077,915.27[9] - Net profit attributable to shareholders was a loss of ¥5,350,650.69, with a year-to-date net profit of ¥22,860,511.96[9] - Basic and diluted earnings per share were both -¥0.007, compared to ¥0.0296 in the same period last year[9] - The net profit for the current period is CNY -5,426,876.19, an improvement compared to CNY -32,642,270.56 in the previous period[40] - The total comprehensive income for the current period is CNY -5,426,876.19, compared to CNY -30,441,238.79 in the previous period[41] - The company reported a significant increase in investment income of 2,145.16% to ¥6,826,084.05 from ¥304,036.20 due to gains from the disposal of subsidiary equity[16] - The company reported an investment income of CNY 6,826,084.05 for the current period, with no investment income reported in the previous period[39] Assets and Liabilities - Total assets decreased by 28.26% to ¥880,016,385.41 compared to the end of the previous year[9] - Current liabilities increased from CNY 400,321,585.69 to CNY 769,696,632.97, an increase of approximately 92.2%[31] - Total liabilities rose from CNY 414,445,456.83 to CNY 783,820,020.34, marking an increase of around 89%[31] - Owner's equity decreased from CNY 465,571,412.35 to CNY 442,872,397.02, a decline of about 4.9%[32] - The company has an accumulated deficit of CNY -1,493,317,330.47 in retained earnings[64] Cash Flow - Net cash flow from operating activities decreased by 68.50% to ¥54,803,106.71 year-to-date[9] - Cash received from the sale of goods and services dropped by 77.42% to ¥108,777,383.74 from ¥481,701,890.57, attributed to reduced sales volume[17] - Cash paid for purchasing goods and services decreased by 97.31% to ¥6,885,529.16 from ¥255,705,730.11, reflecting a reduction in procurement volume[17] - The cash inflow from operating activities for Q3 2019 was CNY 135,028,231.07, a decrease from CNY 536,427,055.17 in the previous year[53] - The net cash flow from operating activities for Q3 2019 was CNY 54,803,106.71, a decrease from CNY 173,961,072.91 in the previous period[54] - The company reported a net increase in cash and cash equivalents of CNY 3,059,277.51, contrasting with a decrease of CNY 88,794,846.77 in the previous period[55] Shareholder Information - The company had a total of 39,500 shareholders at the end of the reporting period[11] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management, held 15.46% of shares[11] - No share repurchase transactions were conducted by the top 10 shareholders during the reporting period[13] Inventory and Receivables - Accounts receivable increased significantly by 464.68% to ¥53,050,579.00 from ¥9,394,830.00 as a result of sales of products[16] - Inventory decreased by 73.08% to ¥65,291,855.94 from ¥242,546,184.67 due to product sales[16] Compliance and Audit - There were no violations regarding external guarantees during the reporting period[24] - The company has not undergone an audit for the third quarter report[68] - The company has not disclosed any new product developments or market expansion strategies in this report[68]
中基健康(000972) - 2019 Q3 - 季度财报
2019-10-30 16:00
Financial Performance - Operating revenue fell by 99.21% to ¥799,854.20, with a year-to-date revenue decline of 54.07% to ¥201,077,915.27[10] - Net profit attributable to shareholders was a loss of ¥5,350,650.69, with a year-to-date net profit of ¥22,860,511.96[10] - Basic and diluted earnings per share were both -¥0.007, reflecting an increase of 83.93% compared to the same period last year[10] - Total operating revenue for the current period is CNY 799,854.20, a significant decrease from CNY 101,822,430.00 in the previous period[38] - The net profit for the current period is a loss of CNY 5,426,876.19, compared to a loss of CNY 32,642,270.56 in the previous period, indicating an improvement[40] - The total comprehensive income for the current period is CNY -5,426,876.19, compared to CNY -30,441,238.79 in the previous period[41] - The company reported an operating profit of CNY -6,157,577.56 for the current period, an improvement from CNY -31,859,402.95 in the previous period[40] Cash Flow and Liquidity - Net cash flow from operating activities decreased by 68.50% to ¥57,103,106.71 year-to-date[10] - Cash received from sales of goods and services dropped by 77.42% to ¥108,777,383.74 from ¥481,701,890.57, indicating a decrease in sales volume[17] - The company reported a net cash inflow from the recovery of investments amounting to ¥24,779,960.00, marking a 100% increase from zero[17] - The cash inflow from operating activities for Q3 2019 was CNY 135,028,231.07, down from CNY 536,427,055.17 in the same period last year[53] - The company reported a cash flow net increase of CNY 3,059,277.51, contrasting with a decrease of CNY 88,794,846.77 in the previous period[55] Assets and Liabilities - Total assets decreased by 28.26% to ¥880,016,385.41 compared to the end of the previous year[10] - Current liabilities increased from CNY 400,321,585.69 to CNY 769,696,632.97, an increase of approximately 92.2%[31] - Total liabilities rose from CNY 414,445,456.83 to CNY 783,820,020.34, marking an increase of around 89%[31] - Non-current assets decreased from CNY 607,680,566.17 to CNY 435,503,293.97, representing a reduction of about 28.3%[30] - The company's total liabilities were CNY 783,820,020.34, while total equity stood at CNY 442,872,397.02[64] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 39,500[12] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., holds 15.46% of shares[12] - The company does not have any preferred shareholders[14] - There were no repurchase transactions conducted by the top 10 shareholders during the reporting period[13] Inventory and Receivables - Accounts receivable increased significantly by 464.68% to ¥53,050,579.00 from ¥9,394,830.00 due to sales[16] - Inventory decreased by 73.08% to ¥65,291,855.94 from ¥242,546,184.67, reflecting product sales[16] - The company has a significant amount of other receivables totaling CNY 627,703,543.77, indicating potential liquidity issues[65] Investment and Income - Investment income surged by 2,145.16% to ¥6,826,084.05 from ¥304,036.20, resulting from gains from the disposal of subsidiary equity[16] - The company recorded investment income of CNY 6,826,084.05 in the current period, with no investment income reported in the previous period[38] Tax and Expenses - The company experienced a 99.60% decline in tax refunds received, totaling ¥107,696.61 compared to ¥26,640,018.37 in the previous year[17] - The company incurred tax expenses of CNY 219,960.76 in the current period, a decrease from CNY 1,328,624.62 in the previous period[38] - The company has reported a decrease in management expenses to CNY 10,614,383.90 from CNY 13,261,633.81 in the previous period[38] General Observations - The company has not reported any significant new strategies, product developments, or market expansions during the reporting period[18] - The report indicates that the third-quarter results have not been audited[68] - The company is in compliance with the new financial instrument standards and lease standards effective from 2019[68]
中基健康(000972) - 2019 Q2 - 季度财报
2019-08-29 16:00
Financial Performance - The company's operating revenue for the first half of 2019 was ¥200,278,061.07, a decrease of 40.40% compared to ¥336,010,975.33 in the same period last year[19]. - The net profit attributable to shareholders was ¥28,211,162.65, a significant improvement from a loss of ¥83,846,141.90 in the previous year[19]. - The basic earnings per share increased to ¥0.0366 from a loss of ¥0.1087 in the same period last year[19]. - The company achieved total operating revenue of ¥200,278,061.07, a decrease of 40.40% compared to the same period last year, primarily due to a reduction in sales volume of large-pack tomato sauce[31]. - The net profit attributable to the parent company was ¥28,211,162.65, with net assets attributable to shareholders amounting to ¥466,699,773.21[31]. - The company reported a significant reduction in sales expenses by 99.32% to ¥193,963.95, attributed to decreased delivery costs[33]. - The company reported a net profit of approximately 37.43 million, with a total revenue of about 195.36 million during the reporting period[47]. - The company reported a net loss of CNY 1,465,106,167.82, compared to a loss of CNY 1,493,317,330.47 in the previous period, indicating a slight improvement[134]. - The company reported a decrease in comprehensive income compared to the previous period, highlighting potential operational issues[161]. Cash Flow and Assets - The net cash flow from operating activities was ¥33,811,759.18, down 50.09% from ¥67,745,581.37 year-on-year[19]. - The company’s cash and cash equivalents increased by ¥7,196,289.76, contrasting with a decrease of ¥60,090,593.07 in the previous year[33]. - The company’s cash and cash equivalents decreased from 56,563,185.72 RMB at the end of 2018 to 40,678,330.06 RMB by June 30, 2019, a decline of approximately 28.14%[131]. - The total cash and cash equivalents at the end of the period were CNY 39,992,727.03, compared to CNY 63,658,051.30 at the end of the first half of 2018[148]. - The total assets at the end of the reporting period were ¥1,056,412,838.36, a decrease of 13.88% from ¥1,226,692,417.36 at the end of the previous year[19]. - The total current assets slightly increased from CNY 676,042,336.43 to CNY 677,832,025.34, a marginal increase of about 0.3%[137]. - The company’s fixed assets decreased from CNY 495,465,913.18 to CNY 427,117,772.82, a decline of approximately 13.8%[132]. Expenses and Liabilities - Operating costs decreased by 43.83% to ¥188,703,101.41, reflecting the same decline in sales volume of large-pack tomato sauce[33]. - Financial expenses were reduced by 59.64% to ¥7,978,665.00, resulting from decreased borrowings and interest expenses[33]. - The company's total liabilities decreased from CNY 783,820,020.34 to CNY 585,414,549.82, representing a reduction of approximately 25.3%[134]. - Current liabilities increased from CNY 769,696,632.97 to CNY 571,291,162.45, a decrease of about 25.8%[133]. Strategic Initiatives - The company has been actively pursuing asset restructuring and optimization to improve asset quality and enhance sustainable development capabilities[31]. - The company is in the process of transferring 100% equity of Tianjin Zhongchen Canned Food Co., Ltd., aiming to reduce financial burdens and promote business transformation[45]. - The company plans to utilize capital market financing and restructuring effects to enhance its risk resistance and achieve diversified operations[51]. - The company plans to continue focusing on market expansion and new product development to drive future growth[142]. Legal Matters - The company is involved in a significant legal dispute with MasterCard regarding a leasing contract, with claims for management fees totaling CNY 9,994,740.00 and inventory losses of CNY 18,100,667.52[60]. - The Tianjin Intermediate People's Court ruled in favor of the company, ordering MasterCard to pay the claimed management fees and inventory losses, but MasterCard has appealed the decision[65]. - Red Tomato requested compensation of CNY 12,398,555.95 for economic losses due to non-compliance with shipping instructions from Tianjin Coal Trading Company[71]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 40,412[116]. - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., held 15.46% of shares, totaling 119,243,804 shares[117]. - The second-largest shareholder, Xinjiang Guoheng Investment Development Group Co., held 12.97% of shares, totaling 100,000,000 shares[117]. Environmental and Regulatory Compliance - The company is classified as a key pollutant discharge unit and has implemented a wastewater treatment facility with a processing capacity of 450 m³/H[103]. - The company has established an emergency response plan for environmental incidents and has complied with environmental regulations[103]. Miscellaneous - The half-year financial report has not been audited[58]. - The company did not distribute cash dividends or bonus shares for the half-year period[55]. - There were no stock incentive plans or employee stock ownership plans implemented during the reporting period[88]. - The company has not engaged in any poverty alleviation work during the reporting period and has no future plans for such initiatives[105].
ST中基:关于参加2019年新疆辖区上市公司投资者网上集体接待日活动的公告
2019-07-19 08:40
Group 1: Event Details - The company will participate in the 2019 Xinjiang Listed Companies Investor Online Reception Day on July 26, 2019, from 15:00 to 17:30 [1] - The event will be held online via the platform provided by Shenzhen Panorama Network Co., Ltd. [1] - Investors can access the event through the "Panorama Roadshow World" website or the WeChat public account "Panorama Finance" [1] Group 2: Attendees - The attendees include Chairman Mr. Li Yu, CFO Ms. Luo Qiong, and Secretary of the Board Mr. Xing Jiang [1] Group 3: Company Assurance - The company and its board members guarantee the authenticity, accuracy, and completeness of the announcement, with no false records or misleading statements [1]
中基健康(000972) - 2019 Q1 - 季度财报
2019-04-29 16:00
Revenue and Profitability - The company's revenue for Q1 2019 was ¥91,484,302.22, representing a 93.30% increase compared to ¥47,328,180.62 in the same period last year[8] - The net profit attributable to shareholders was -¥8,966,936.17, a decrease of 10.16% from -¥9,981,246.45 year-on-year[8] - Revenue increased by 93.30% to ¥91,484,302.22 driven by higher sales volume of bulk tomato sauce[15] - Operating profit for Q1 2019 was a loss of CNY 9,175,350.13, compared to a loss of CNY 11,277,169.72 in the previous year, showing an improvement of 18.6%[34] - The net profit for the first quarter was -9,035,125.01, an improvement from -10,923,594.92 in the previous period, showing a reduction in losses[36] - The total comprehensive income for the first quarter was -9,035,125.01, compared to -11,816,701.26 in the previous period, showing an improvement[36] Cash Flow and Liquidity - The net cash flow from operating activities was -¥13,002,306.18, compared to ¥6,407,367.83 in the previous year, indicating a significant decline[8] - Cash received from sales dropped by 85.58% to ¥21,623,066.04, primarily due to reliance on accounts receivable[15] - The company received cash from operating activities totaling 23,488,846.89, down from 197,344,569.85 in the previous period[43] - The net cash flow from financing activities was -16,172,991.27 CNY, resulting in a total cash and cash equivalents balance of 39,973,833.69 CNY at the end of the period[44] - The net cash flow from investment activities was 12,585,950.69 CNY, primarily from cash received for investment recovery[47] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,142,589,492.98, down 6.86% from ¥1,226,692,417.36 at the end of the previous year[8] - The total assets decreased from ¥1,226,692,417.36 to ¥1,142,589,492.98, reflecting a decline in both current and non-current assets[27] - Total liabilities decreased to CNY 55,333,694.43 from CNY 48,749,467.05, reflecting an increase of 13.1%[33] - The company reported a total equity attributable to shareholders of 438,488,610.56 CNY, with a negative retained earnings of -1,493,317,330.47 CNY[51] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 42,033[10] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., held 15.46% of the shares[10] Inventory and Operating Costs - Operating costs surged by 165.80% to ¥87,733,345.57, also attributed to increased sales volume of bulk tomato sauce[15] - Inventory decreased by 34.71% to ¥158,354,275.81 due to product sales[15] - The company’s inventory stood at 242,546,184.67 CNY, indicating a significant asset allocation towards stock[50] Financial Ratios and Performance Metrics - The basic earnings per share were -¥0.0116, an improvement of 10.08% compared to -¥0.0129 in the same period last year[8] - The weighted average return on net assets was -2.20%, a decrease of 0.96 percentage points from -1.24% year-on-year[8] - The company reported operating expenses of 3,238,859.19, down from 3,567,405.54 in the previous period, reflecting cost control efforts[38] Other Financial Information - The company reported no non-recurring gains or losses during the reporting period[8] - The company reported an undistributed profit of -1,233,900,002.58, indicating a significant loss[54] - The first quarter report was not audited, which may affect the reliability of the financial data presented[56] - The company adopted new financial instrument standards effective January 1, 2019, without retrospective adjustments affecting prior years[55]
中基健康(000972) - 2018 Q4 - 年度财报
2019-04-29 16:00
Financial Performance - The company's operating revenue for 2018 was ¥626,669,589.53, representing a 21.05% increase compared to ¥517,710,604.78 in 2017[17] - The net profit attributable to shareholders was -¥423,854,369.08, a significant decline from a profit of ¥36,689,853.12 in the previous year[17] - The net cash flow from operating activities improved to ¥416,334,994.00, compared to -¥176,181,920.66 in 2017[17] - Total assets at the end of 2018 were ¥1,226,692,417.36, a decrease of 47.74% from ¥2,445,329,852.45 in 2017[18] - The net assets attributable to shareholders decreased by 50.06% to ¥438,488,610.56 from ¥882,362,014.79 in 2017[18] - The basic earnings per share for 2018 was -¥0.55, down from ¥0.05 in 2017[17] - The weighted average return on equity was -64.39%, a decline of 67.49 percentage points from 4.28% in the previous year[17] - The company reported a net profit attributable to shareholders of -¥430,466,467.26, indicating ongoing financial challenges[36] Revenue Breakdown - The manufacturing sector contributed ¥613,359,200.82, accounting for 97.88% of total revenue, with a year-on-year growth of 22.79%[41] - The large bucket tomato sauce sales reached ¥519,702,876.01, which is 82.93% of total revenue, showing a significant increase of 77.49% compared to the previous year[41] - Domestic sales surged to ¥546,859,634.70, a remarkable increase of 141.56% from ¥226,383,514.18, while international sales plummeted by 72.60% to ¥79,809,954.83[41] - The total revenue for 2018 was 630,820,848.05 CNY, a decrease of 21.38% compared to 2017[44] - Domestic sales accounted for 533,549,245.99 CNY, down 15.52% year-over-year, while international sales dropped by 37.96% to 79,809,954.83 CNY[44] Operational Challenges - The company has faced significant financial challenges, as indicated by the substantial losses reported in the net profit figures[17] - The gross profit margin for the manufacturing sector fell to -18.44%, reflecting a significant decline in profitability[43] - The company is facing high production costs and insufficient operational funds, leading to significant financial pressure[38] - The company decided to halt production at certain subsidiaries to mitigate losses due to reduced tomato supply and rising costs, providing a necessary opportunity for reform[37] Strategic Plans and Investments - The company plans to enhance its market competitiveness by optimizing resource allocation and improving asset quality, including the shutdown of certain subsidiaries[27] - The company has invested in mechanized harvesting, which can reduce labor costs by 40%-60%, thereby improving efficiency and quality in tomato production[31] - The company aims to combine asset management with capital operations to ensure sustainable and stable development[27] - The company is focusing on developing high-value-added products such as tomato health cosmetics and beverages to enhance profitability[74] - The company is exploring mergers and acquisitions to expand its business scope in the health industry and increase profit growth points[74] Legal Matters - The company has filed a lawsuit against Tianjin Master Printing and Iron Packaging Co., Ltd. for a lease contract dispute, claiming a total compensation of 67,877,894.95 yuan, which includes management fees, advances, and guarantee deposits[99] - The company has been involved in multiple legal disputes, including a case against its subsidiary Tianjin Zhongchen Canned Co., Ltd. for a total debt of 27,286,749.53 yuan[102] - The ongoing legal disputes highlight the complexities and risks associated with logistics and supply chain contracts in the industry[110] Environmental and Social Responsibility - The company has established an emergency response plan for environmental incidents, in accordance with the Environmental Protection Law of the People's Republic of China[145] - The company has created over 4,000 long-term fixed job opportunities and provided 8,000 seasonal job opportunities annually in Xinjiang[137] - The company is recognized as a key agricultural industrialization leading enterprise and has contributed significantly to the economic development of Xinjiang[136] Governance and Management - The company is focused on maintaining a strong governance structure with independent directors and supervisors to ensure compliance and accountability[166] - The management team includes experienced professionals with extensive backgrounds in investment and project management, which is crucial for the company's growth strategy[171] - The company has established a performance evaluation and incentive mechanism based on a fair and transparent salary system[185] Future Outlook - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 1.32 billion RMB[178] - New product launches are expected to contribute an additional 200 million RMB in revenue, with a focus on health supplements and organic products[178] - The company aims to improve operational efficiency, targeting a reduction in production costs by 8% through process optimization[178]
中基健康(000972) - 2018 Q3 - 季度财报
2018-10-30 16:00
Financial Performance - Operating revenue for the current period was CNY 101,822,430.00, a decrease of 46.86% year-on-year[9] - Net profit attributable to shareholders was a loss of CNY 33,374,719.87, with a year-to-date loss of CNY 117,220,861.77[9] - Basic earnings per share for the current period was -0.0433 CNY, with a year-to-date figure of -0.1520 CNY[9] - Weighted average return on net assets was -4.25%, a decrease of 18.36 percentage points year-on-year[9] - Net profit attributable to shareholders of the parent company was a loss of ¥117,220,861.77, a decrease of 246.71% compared to the previous year[18] - Basic earnings per share dropped by 246.72% to -0.1520 due to increased losses[18] - Total operating revenue for the current period is ¥101,822,430, a decrease of 47% from ¥191,611,687.47 in the previous period[40] - Net profit for the current period is -¥32,642,270.56, compared to a net profit of ¥192,598,098.44 in the previous period, indicating a significant decline[41] - The company reported a gross loss of ¥31,859,402.95 for the current period, worsening from a loss of ¥25,371,450.52 in the previous period[41] - Total comprehensive income for the current period is -¥29,307,373.94, compared to ¥191,727,228.44 in the previous period[41] - Operating profit for the current period is -¥3,973,724.90, a decline from ¥22,308,551.89 in the previous period[42] - The net profit for Q3 2018 was -121,580,443.13 CNY, compared to a profit of 151,228,278.96 CNY in the same period last year, indicating a significant decline[46] - The company reported a comprehensive income total of -130,996,067.52 CNY for Q3 2018, down from 152,540,238.96 CNY in the same quarter last year[46] Asset and Liability Changes - Total assets decreased by 29.83% to CNY 1,715,869,991.36 compared to the end of the previous year[9] - Net assets attributable to shareholders decreased by 13.99% to CNY 758,926,840.92 compared to the end of the previous year[9] - Cash and cash equivalents decreased by 71.75% to ¥34,953,797.60 due to repayment of loans and accounts payable[18] - Inventory decreased by 34.90% to ¥586,497,529.29 as a result of product sales[18] - Long-term equity investments decreased by 100% to ¥0 due to the consolidation of Tianjin Zhongchen Can Co., Ltd.[18] - Total liabilities decreased from CNY 1,560,278,681.93 to CNY 961,814,888.37, a decrease of about 38.3%[35] - The total equity attributable to shareholders decreased from CNY 882,362,014.79 to CNY 758,926,840.92, a decline of about 14%[35] - Current assets decreased from CNY 1,273,721,025.17 to CNY 722,357,492.64, a reduction of about 43.3%[33] - The non-current assets decreased from CNY 1,171,608,827.28 to CNY 993,512,498.72, a reduction of approximately 15.2%[33] Cash Flow Analysis - Cash flow from operating activities for the year-to-date was CNY 173,961,072.91[9] - Cash received from tax refunds decreased by 46.95% to ¥26,640,018.37 due to reduced export tax rebates[19] - Cash paid for purchasing goods and services decreased by 48.01% to ¥255,705,730.11 due to reduced production[19] - Cash received from borrowings decreased by 64.26% to ¥89,000,000.00 compared to the previous year[19] - Cash inflow from operating activities totaled ¥23,567,966.49, a decrease of 46.8% from ¥44,338,981.78 in the previous period[55] - Cash outflow from operating activities increased significantly to ¥20,675,401.53, compared to ¥8,972,056.94 in the previous period, marking a rise of 130.5%[55] - The total cash outflow from financing activities was -262,268,494.93 CNY, compared to a net inflow of 6,514,243.61 CNY in the previous year, indicating a shift towards higher cash outflows[53] - The company received 89,000,000.00 CNY in borrowings during the period, compared to 249,000,000.00 CNY in the previous year, showing a decrease in new debt financing[53] Operational Costs - Operating costs increased by 35.43% to ¥435,788,547.30 driven by increased sales volume of bulk tomato sauce[18] - Total operating costs for the current period are ¥134,028,284.48, down 38.5% from ¥216,983,137.99 in the previous period[40] - The company incurred management expenses of 10,043,426.21 CNY, slightly higher than 9,793,756.59 CNY in the previous year, reflecting increased operational costs[49] - Financial expenses for the current period are ¥25,986,071.41, a decrease from ¥28,444,190.63 in the previous period[44] - The financial expenses for the period were 3,968,503.93 CNY, down from 4,270,777.44 CNY in the previous year, indicating a reduction in financing costs[49] Shareholder Information - The company reported no significant changes in shareholder structure during the reporting period[14] - There were no preferred shareholders as of the end of the reporting period[15] Other Information - The company has not disclosed any new product developments or market expansion strategies in the current report[58] - The third quarter report has not been audited, which may affect the reliability of the financial data presented[58]
中基健康(000972) - 2018 Q2 - 季度财报
2018-08-24 16:00
Financial Performance - The company's operating revenue for the first half of 2018 was ¥336,010,975.33, representing a 90.95% increase compared to ¥175,970,904.72 in the same period last year[19]. - The net profit attributable to shareholders of the listed company was -¥83,846,141.90, compared to -¥40,068,245.37 in the previous year, indicating a significant loss[19]. - The net cash flow from operating activities increased by 109.01% to ¥67,745,581.37 from ¥32,412,535.80 year-on-year[19]. - The basic earnings per share were -¥0.1087, compared to -¥0.0520 in the same period last year[19]. - The weighted average return on net assets was -9.98%, a decrease of 5.04 percentage points compared to -4.94% in the previous year[19]. - The net profit attributable to shareholders was -¥83,846,141.90, worsening the loss by ¥43,777,896.53 year-on-year[31]. - The operating costs rose to ¥335,932,957.78, a 124.15% increase year-on-year, primarily due to increased sales volume of large-pack tomato sauce[35]. - The gross profit margin for the manufacturing sector decreased by 14.88% year-on-year, attributed to a prolonged market downturn and low sales prices[37]. - The net loss for the period was CNY 88,938,172.57, compared to a net loss of CNY 41,369,519.48 in the previous year, indicating a worsening financial performance[146]. Assets and Liabilities - Total assets decreased by 23.47% to ¥1,871,493,130.15 from ¥2,445,329,852.45 at the end of the previous year[19]. - The net assets attributable to shareholders of the listed company decreased by 10.46% to ¥790,100,529.02 from ¥882,362,014.79 at the end of the previous year[19]. - The company’s total assets and net assets are expected to significantly improve following the acquisition of Taihe Biochemical, enhancing profitability and asset quality[32]. - The total liabilities decreased from CNY 1,560,278,681.93 to CNY 1,088,130,653.22, showing a reduction in the company's debt levels[139]. - The total equity attributable to shareholders decreased from CNY 882,362,014.79 to CNY 790,100,529.02, indicating a decline in shareholder value[139]. Cash Flow - The company’s cash and cash equivalents decreased by ¥60,090,593.07, compared to a decrease of ¥14,487,464.32 in the previous year[35]. - The cash and cash equivalents at the end of the period amount to 63,658,051.30, down from 175,818,082.15 in the previous period, indicating a decrease of approximately 63.70%[153]. - The net cash flow from operating activities is 67,745,581.37, an increase from 32,412,535.80 in the previous period, showing a growth of about 108.67%[152]. - The total cash outflow from financing activities was 54,449,041.67, resulting in a net cash flow from financing activities of -34,449,041.67[156]. Strategic Plans and Acquisitions - The company plans to acquire 100% equity of Taihe Biochemical through a share issuance, aiming to enhance its dual main business structure in tomato and citric acid industries[32]. - The company plans to dispose of certain subsidiary equity to optimize resource allocation and improve asset structure[33]. - The company plans to continue optimizing its tomato product structure, focusing on the development and promotion of high-value-added tomato health products and beverages[58]. Legal and Compliance Issues - The company has faced risks related to weather conditions affecting tomato production and high market competition in the tomato sauce industry[56]. - The company has been involved in multiple legal disputes with MasterCard and Zhongchen Cans regarding contract violations and payment defaults[77]. - Zhongji Health has faced significant legal challenges, including multiple lawsuits related to contract breaches and financial obligations[80]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 46,298[119]. - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., holds 15.46% of the shares[119]. - There were no changes in the controlling shareholder or actual controller during the reporting period[122]. Corporate Governance - The company has not engaged in any derivative investments or sold any significant assets or equity during the reporting period[49][50][51]. - The financial report for the half-year period was not audited[134]. - The integrity status of the company and its controlling shareholders is good, with no unfulfilled court judgments or significant overdue debts[91]. Operational Highlights - The company operates in the food processing industry, with a focus on health and medical technology investments[174]. - The company has established wastewater treatment facilities that meet discharge standards, with a treatment capacity of 450m3/H[108]. - The company has entered into a lease agreement for a total area of 60,000 square meters of land and 36,900 square meters of factory space for 8 years[102].